Dyaningtyas Dewi Pamungkas Putri

5PUBLICATIONS
14CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 24, 2025
In Silico Analysis Reveals MDM2 as a Potential Target of Ursolic Acid for Overcoming Tamoxifen Resistance in Breast Cancer.

Yohanes Surya Jati, Diyah Novi Sekarini, Nur Ayunie Zulkepli

|Jul 19, 2025
Discovery of pyroptosis-inducing natural products in neuroblastomas: computational studies with experimental validation.

Beni Lestari, Rohmad Yudi Utomo, Faaza Aulia Rahman

|Dec 04, 2024
The Combination of Sorafenib and PGV-1 Inhibits the Proliferation of Hepatocellular Carcinoma Through c-Myc Suppression in an Additive Manner: In Vitro Studies.

Dhania Novitasari, Ikuko Nakamae, Noriko Yoneda-Kato

|May 09, 2024
Nobiletin Inhibits Breast Cancer Stem Cell by Regulating the Cell Cycle: A Comprehensive Bioinformatics Analysis and In Vitro Experiments.

Adam Hermawan, Muthi Ikawati, Dyaningtyas Dewi Pamungkas Putri

Pageof 1